-
Drugmaker agrees to pay more than $1 billion in Paxil settlements
Wednesday, July 28, 2010
Bloomberg BusinessWeek: “GlaxoSmithKline Plc has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children,” according to a Bloomberg report. That brings the total Glaxo has agreed to pay to settle Paxil-related suits to more than $2 billion.
No related posts.
Tags: drug safety, pharmaceutical companies, pharmaceuticals;
Category: In The News;